NYMC Faculty Publications
Indications and Outcomes of PPM and ICD Placement
Author Type(s)
Faculty
DOI
10.1007/978-3-031-99282-7_21
Journal Title
Hypertrophic Cardiomyopathy
First Page
295
Last Page
311
Document Type
Article
Publication Date
1-1-2025
Department
Medicine
Keywords
Appropriate implantable cardioverter-defibrillator, Device programming, Hypertrophic cardiomyopathy, Implantable cardioverter-defibrillator, Inappropriate implantable cardioverter-defibrillator, Pacemaker, Sudden cardiac death
Abstract
The use of synchronized atrioventricular (AV) pacing devices and implantable cardioverter-defibrillators (ICDs) plays a critical role in the management of hypertrophic cardiomyopathy (HCM). Indications for pacing and defibrillators follow the standard guidelines for treatment of conduction disease and arrhythmias in the general population, with distinct additional indications for HCM patients based on the potential to mitigate diastolic dysfunction and outflow tract gradients and the potential to prevent and treat life-threatening ventricular arrhythmia and sudden cardiac death. ICDs can be a life-saving therapy in high-risk HCM patients, but the early placement of these devices in younger patients may expose them to a higher lifetime risk of complications. Given the unique nature of HCM, specific procedural and programming considerations should be taken into account.
Recommended Citation
Jacobson, J., Frenkel, D., & Germano, J. (2025). Indications and Outcomes of PPM and ICD Placement. Hypertrophic Cardiomyopathy, 295-311. https://doi.org/10.1007/978-3-031-99282-7_21
